Hotta K, Matsuzawa Y
Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University.
Nihon Rinsho. 2001 Mar;59(3):481-6.
Visceral fat accumulation often accompanies various complications, such as insulin resistance, hypertension, dyslipidemia and atherosclerosis. Adipose tissue has been found to secrete various biologically active adipocytokines including free fatty acids. Accumulation of visceral fat increases the portal free fatty acids concentration to cause insulin resistance and dyslipidemia. Tumor necrosis alpha (TNF alpha) deteriorates insulin resistance in obesity. The levels of plasminogen activator inhibitor(PAI)-1 increase and plasma adiponectin concentration decreases in obesity leading to the development of vascular disease. The finding of genes specifically expressed in visceral fat and new adipocytokines should facilitate clarification of the mechanism for the development and complications of visceral fat accumulation.
内脏脂肪堆积常伴有各种并发症,如胰岛素抵抗、高血压、血脂异常和动脉粥样硬化。已发现脂肪组织会分泌包括游离脂肪酸在内的多种生物活性脂肪细胞因子。内脏脂肪堆积会增加门静脉游离脂肪酸浓度,从而导致胰岛素抵抗和血脂异常。肿瘤坏死因子α(TNFα)会使肥胖症中的胰岛素抵抗恶化。肥胖症中纤溶酶原激活物抑制剂(PAI)-1水平升高,血浆脂联素浓度降低,导致血管疾病的发生。在内脏脂肪中特异性表达的基因以及新的脂肪细胞因子的发现,应有助于阐明内脏脂肪堆积的发生机制及其并发症。